By disrupting the KRAS signaling pathway, sotorasib inhibits cell growth as well as tumor progression both in vitro and in vivo and induces apoptosis in KRAS p.G12C tumor cell lines (86, 87). The gene discussed is KRAS; the disease is neoplasm.